Where Global Innovation
and Capital Meet

Healthcare

10 spinouts to watch: November 2022

Cures for HIV and blurred vision and using cosmic rays to monitor nuclear waste drums are on our list of recent promising university spinouts.

Nov 21, 2022

CasInvent Pharma goes for cancer hat-trick

CasInvent Pharma’s approach is aimed at three forms of cancer rather than just one, with leukaemia, lymphoma and solid tumours all in its sights.

Nov 1, 2022

10 spinouts to watch: October 2022

Non-recyclable plastics making asphalt more sustainable and a vaccine to save the honeybee are just two of 10 inventions that caught our eye.

Oct 3, 2022

Half of all vaccines are wasted — EnsiliTech wants to change that

About half of all vaccines are wasted due to challenges surrounding cold chain logistics, so EnsiliTech aims to remove the need for cold storage.

Sep 22, 2022

10 spinouts to watch: September 2022

Spinouts working on ketamine-based therapeutics, regenerative medicines for dogs and better sleep are among those that caught our eye this month.

Sep 14, 2022

10 spinouts to watch: August 2022

These are the spinouts that caught our eye over the past month. Here's why they should be on your radar, too.

Aug 3, 2022

Cleerly captures investors’ hearts in $192m series C

Launched just a year ago to build on work at Weill Cornell Medicine and New York-Presbyterian Hospital, Cleerly has now closed an oversubscribed series C round.

Jul 25, 2022

Other News

CardiaTec captures $1.7m

Cambridge Enterprise has put cash into CardiaTec Biosciences in a pre-seed round that marks the inaugural deal for Laidlaw Scholars Ventures.

Jul 6, 2022

ReCode registers $120m series B extension

UT Southwestern Medical Center spinout ReCode Therapeutics has now raised a total of $200m in its series B round from investors including Osage University Partners.

Jun 30, 2022

MicroTransponder manifests $53m series E

Osage University Partners has added MicroTransponder to a small but mightly portfolio of medical device companies.

Jun 23, 2022

Carma clinches $50m first close

Ascenion and Goethe University Frankfurt are among the initiators of Carma Fund I, which will help start up and fund early life science projects.

Jun 21, 2022

Elypta elicits $21m series A

Chalmers spinout Elypta is working on a metabolism-based liquid biopsy for early cancer detection that it hopes will catch any type of the disease.

Jun 21, 2022

Deals: June 1, 2022

Orphan CNS therapy developer Minoryx Therapeutics closed a $54.8m series C and MIT's The Engine co-led a $10.5m seed round for Foundation Alloy.

Jun 1, 2022

Editor's Picks

9 startups that aim to make us live longer

Corporate investors are backing a host of elder-care startups, from those seeking Parkinson's cures to apps aiding mental wellbeing.

Nov 22, 2022

Pixie Dust Technologies explores "magic touch" dementia treatment 

A Japan-based university spinout is exploring a sound and touch treatment for dementia.

Nov 22, 2022

The Big Deal: Acrivon gives the IPO market a boost

The cancer drug developer popped after an upsized offering, allowing Alexandria Venture Investments to exit and showing the IPO market is still breathing in the US.

Nov 18, 2022

Simplyhealth launches fund to invest in disease management

The UK health insurer says it is a good time to launch a fund as the froth has come out of valuations and "sensible" money can go in.

Nov 15, 2022
© 2021 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here